Material Agreement (Form 8-K)

Item 1.01. Entry into a Material Definitive Agreement.

On October 16, 2026, Genvor Incorporated (the "Company") issued to Dr. Jesse Jaynes, a member of the Company's Board of Directors and the Company's Chief Scientific Officer, a promissory note (the "Jaynes Note"), in consideration of Dr. Jaynes' funding of $20,000 to the Company on October 8, 2026. The Jaynes Note includes a 2% original issue discount such that the original principal amount due to be paid to Dr. Jaynes is $20,408.16. The Jaynes Note accrues interest at the rate of 15% per annum, matures on April 8, 2027 (six months after funding), and is not convertible into equity of the Company.

On October 16, 2026, the Company issued to Dr. Clayton Yates, a member of the Company's Board of Directors, a promissory note (the "Yates Note"), in consideration of Dr. Yates' funding of $10,000 to the Company on October 8, 2026. The Yates Note includes a 2% original issue discount such that the original principal amount due to be paid to Dr. Yates is $10,204.08. The Yates Note accrues interest at the rate of 15% per annum, matures on April 8, 2027 (six months after funding), and is not convertible into equity of the Company.

The foregoing descriptions of the Jaynes Note and the Yates Note do not purport to be complete and are qualified in their entirety by reference to the full text of those promissory notes, copies of which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated by reference herein.